Bioactive coatings on metallic implants facilitate joining between the prosthesis and the osseous tissue, and increase the long-term stability and integrity of the implant. These are thin films coated on medical devices to deter bacterial adhesion, improve core functionality of the device, and impart bioactivity along with biocompatibility to the device. One of the earliest successful bioactive coatings was that of heparin-modified surface of a polymer blood oxygenator component trademarked as Caemeda Affinity Blood Oxygenator, Trillium Affinity NT Blood Oxygenator, which received FDA approval.

Increasing number of bioactive coating medical devices used for surgeries and medical device implants are the major driver for the bioactive materials for coating.

Implantable devices containing thin films of bioactive molecules are rapidly gaining adoption in therapeutic areas of cardiology and orthopedic joint diseases – the two major sources of loss of quality of life and disability currently. Bioactive molecules and generic factors such as increasing incidence of systemic joint diseases, cardiovascular implant and support are driving the demand for bioactive coating devices across the globe. On the other hand, lack of research awareness, high requirement for funding for continued research, and less-developed research infrastructure in middle and low income countries among others are the restraints of market.

To request a sample copy or view summary of this report, click the link below:

The global market for bioactive coating devices is segmented on the basis of product type, by medical application, by material, and by end-user.

On the basis of product type, the global market is classified into
Anti-microbial coatings- also termed as self-fertilizing coatings. Antimicrobial coatings on textiles prevent the degradation of textile fibers, limit the incidence of bacteria, reduce the formation of odor following the microbial degradation of perspiration, and protect users by avoiding the transfer and spread of pathogens.

Hydrophilic coatings- This coating can be applied to many instruments such as catheters, canulas, and guidewires to prevent or at the very least reduce the amount of damage and inflammation they cause when being used on a patient.

Drug Eluting coating- They are statistically superior to bare-metal stents for the treatment of native coronary artery narrowings., and others (including Anti-thrombogenic coatings). Antimicrobial coatings are expected to grow gradually during the forecast period from 2014 to 2025 with maximum market share.

See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s